GL1X · GenesisL1 explorer

MolNFT v1 · #80517 · protein

Kinase domain of csrc in complex with RL130

3TZ9 · Proto-oncogene tyrosine-protein kinase src: “Kinase domain of csrc in complex with RL130”. X-ray diffraction, 1 ligand (AQU), 4 pockets (best druggability 0.74). MolNFT v1 #80517 on GenesisL1: 3D structure, binding sites and pockets…

PDB
3TZ9
Type
protein
Length
520 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
AQU
Pockets
4 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26140% helix, 16% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein25941% helix, 15% strandP00523

Ligands and binding sites

  • AQU · 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-[4-(quinazolin-4-ylamino)phenyl]urea · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19710.740.7791AQU
23240.720.8531AQU
33640.600.7741empty
4510.260.7312empty

Interfaces

1 interface between chains.

  • A–B · 327 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 3TZ9 · Kinase domain of cSrc in complex with RL130 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.